Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappa B

Citation
E. Ayroldi et al., Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappa B, BLOOD, 98(3), 2001, pp. 743-753
Citations number
66
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
98
Issue
3
Year of publication
2001
Pages
743 - 753
Database
ISI
SICI code
0006-4971(20010801)98:3<743:MOTABT>2.0.ZU;2-V
Abstract
Previously a novel gene was identified that encodes a glucocorticoid-induce d leucine zipper (GILZ) whose expression is up-regulated by dexamethasone. This study analyzed the role of GILZ in the control of T-cell activation an d its possible interaction with nuclear factor kappaB (NF-kappaB). Results indicate that GILZ inhibits both T-cell receptor (TCR)-induced interleukin- 2/interleukin-2 receptor expression and NF-kappaB activity. In particular, GILZ inhibits NF-kappaB nuclear translocation and DNA binding due to a dire ct protein-to-protein interaction of GILZ with the NF-kappaB subunits. More over, GILZ-mediated modulation of TCR-induced responses is part of a circui t because TCR triggering down-regulates GILZ expression. These results iden tify a new molecular mechanism involved in the dexamethasone-induced regula tion of NF-kappaB activity and T-cell activation. (C) 2001 by The American Society of Hematology.